347 related articles for article (PubMed ID: 12606953)
21. Comparative genomic hybridization analysis of PhIP-induced mammary carcinomas in rats reveals a cytogenetic signature.
Christian AT; Snyderwine EG; Tucker JD
Mutat Res; 2002 Sep; 506-507():113-9. PubMed ID: 12351150
[TBL] [Abstract][Full Text] [Related]
22. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
[TBL] [Abstract][Full Text] [Related]
23. Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
Shan L; Yu M; Snyderwine EG
Toxicol Pathol; 2005; 33(7):768-75. PubMed ID: 16316942
[TBL] [Abstract][Full Text] [Related]
24. Analysis of EGFR, TGF-alpha, neu and c-myc in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary tumors using RT-PCR.
Davis CD; Snyderwine EG
Carcinogenesis; 1995 Dec; 16(12):3087-92. PubMed ID: 8603490
[TBL] [Abstract][Full Text] [Related]
25. Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Snyderwine EG; Venugopal M; Yu M
Mutat Res; 2002 Sep; 506-507():145-52. PubMed ID: 12351154
[TBL] [Abstract][Full Text] [Related]
26. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies.
Shirai T; Tamano S; Sano M; Masui T; Hasegawa R; Ito N
Princess Takamatsu Symp; 1995; 23():232-9. PubMed ID: 8844814
[TBL] [Abstract][Full Text] [Related]
27. Proliferation, development and DNA adduct levels in the mammary gland of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a high fat diet.
Snyderwine EG; Davis CD; Schut HA; Roberts-Thomson SJ
Carcinogenesis; 1998 Jul; 19(7):1209-15. PubMed ID: 9683179
[TBL] [Abstract][Full Text] [Related]
28. Lack of enhancing effects of sodium nitrite on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague-Dawley rats.
Kitamura Y; Yamagishi M; Okazaki K; Furukawa F; Imazawa T; Nishikawa A; Hirose M
Cancer Lett; 2006 Apr; 235(1):69-74. PubMed ID: 15951105
[TBL] [Abstract][Full Text] [Related]
29. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods.
Shirai T; Sano M; Tamano S; Takahashi S; Hirose M; Futakuchi M; Hasegawa R; Imaida K; Matsumoto K; Wakabayashi K; Sugimura T; Ito N
Cancer Res; 1997 Jan; 57(2):195-8. PubMed ID: 9000552
[TBL] [Abstract][Full Text] [Related]
30. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.
Cheung SY; Yuen MT; Choi HL; Cheng HK; Huang Y; Chen S; Chan FL
Int J Oncol; 2003 Jun; 22(6):1383-95. PubMed ID: 12739009
[TBL] [Abstract][Full Text] [Related]
31. The Mcs7 quantitative trait locus is associated with an increased susceptibility to mammary cancer in congenic rats and an allele-specific imbalance.
Cotroneo MS; Merry GM; Haag JD; Lan H; Shepel LA; Gould MN
Oncogene; 2006 Aug; 25(36):5011-7. PubMed ID: 16568087
[TBL] [Abstract][Full Text] [Related]
32. Possible role of Stat5a in rat mammary gland carcinogenesis.
Shan L; Yu M; Clark BD; Snyderwine EG
Breast Cancer Res Treat; 2004 Dec; 88(3):263-72. PubMed ID: 15609129
[TBL] [Abstract][Full Text] [Related]
33. Alteration of gene expression in rat mammary tumors induced by N-methyl-N-nitrosourea.
Young LH; Yang X; Voigt JM
Mol Carcinog; 1996 Apr; 15(4):251-60. PubMed ID: 8634083
[TBL] [Abstract][Full Text] [Related]
34. Characterization of peroxisome proliferator-activated receptor alpha in normal rat mammary gland and 2-amino-l-methyl-6-phenylimidazo[4, 5-b]pyridine-induced mammary gland tumors from rats fed high and low fat diets.
Roberts-Thomson SJ; Snyderwine EG
Toxicol Lett; 2000 Dec; 118(1-2):79-86. PubMed ID: 11137312
[TBL] [Abstract][Full Text] [Related]
35. Genetic alterations in HCA-induced tumors.
Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
[TBL] [Abstract][Full Text] [Related]
36. Inherited susceptibility and acquired allelic imbalance in rat mammary carcinogenesis.
Gould MN; Lubet RA; Kelloff GJ; Haag JD
J Cell Biochem Suppl; 1996; 25():37-40. PubMed ID: 9027596
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression and phosphorylation of 4E-BP1, a main target of mTOR signaling, in rat mammary carcinomas: an association with etiology.
Takabatake M; Daino K; Imaoka T; Nishimura M; Morioka T; Fukushi M; Shimada Y
In Vivo; 2011; 25(6):853-60. PubMed ID: 22021677
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Hikosaka A; Asamoto M; Hokaiwado N; Kato K; Kuzutani K; Kohri K; Shirai T
Carcinogenesis; 2004 Mar; 25(3):381-7. PubMed ID: 14656947
[TBL] [Abstract][Full Text] [Related]
39. Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms.
Snyderwine EG
Cancer Lett; 1999 Sep; 143(2):211-5. PubMed ID: 10503906
[TBL] [Abstract][Full Text] [Related]
40. Inflammation does not precede or accompany the induction of preneoplastic lesions in the colon of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-fed rats.
Kühnel D; Taugner F; Scholtka B; Steinberg P
Arch Toxicol; 2009 Aug; 83(8):763-8. PubMed ID: 19212758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
